Julia Sabine Wahl

Partner at Copenhagen Economics, Brussels

Speaker

Julia is a leading partner in Copenhagen Economics’ Healthcare & Life Sciences service. The CE Healthcare & Life Sciences team combines the best of two worlds – health economics and competition economics – to serve clients in the healthcare and life sciences space. Julia’s expertise spans policy, regulatory and competition matters.

From global pharmaceutical firms and industry organization to policy makers, patient organization and multi-stakeholder groups, Julia and her team drive impactful solutions based on hard facts and clear stories. Recent projects include:

• Assisting global pharma companies in abuse of dominance cases, with a special focus on pricing abuses
• Helping global pharmaceutical and biotech companies evaluate the impacts of regulatory changes on their pipeline
• Acting as a knowledge partner to the European Expert Group on Orphan Drug Incentives, a multi-stakeholder group developing policy proposals for the review of the Orphan Medicinal Products (OMP) Regulation
• Helping pharmaceutical organisations input into policy decision making through compelling evidence (see e.g. recent studies conducted for Novo Nordisk or Takeda)
• Supporting pharmaceutical companies shape difficult launch environments using health economic methods
• Helping patient organisations convey the burden of diseases and advocate for policy action